Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Distinguishing Ile/Leu Variant Ligands in the Immunopeptidome Using Hybrid EAD + CID Fragmentation (ExCID).

Analytical chemistry·2026

Same author

Cancer epitope prediction tools and analysis pipelines in CEDAR.

Nucleic acids research·2026

Same author

NetMHCIIphosPan: A Machine Learning Tool for Predicting HLA Class II Antigen Presentation of Phosphorylated Peptides.

Journal of proteome research·2026

Same author

Ellagic acid metabolism as a source of dietary MR1 ligands.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same author

Conserved CD4<sup>+</sup> T cell staphylococcal and streptococcal epitopes enable broad-acting vaccines in mice.

Nature microbiology·2026

Same author

NetMHCIIphosPan: a machine learning tool for predicting HLA class II antigen presentation of phosphorylated peptides.

bioRxiv : the preprint server for biology·2026

Same journal

Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026

Same journal

TGF-β controls developmental fate and functional identity of thymic γδ T cells.

Journal of immunology (Baltimore, Md. : 1950)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 20, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

HLA Class II Specificity Assessed by High-Density Peptide Microarray Interactions.

Thomas Osterbye¹, Morten Nielsen^2,3, Nadine L Dudek⁴

¹Department of Immunology and Microbiology, University of Copenhagen, DK-2200 Copenhagen, Denmark; thos@sund.ku.dk.

Journal of Immunology (Baltimore, Md. : 1950)

|June 3, 2020

Summary

This summary is machine-generated.

Developing accurate MHC class II (MHC-II) prediction tools is crucial for immunotherapy. This study generated large-scale peptide binding data using high-density arrays, significantly improving MHC-II prediction capabilities.

More Related Videos

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Related Experiment Videos

Last Updated: Dec 20, 2025

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

Area of Science:

Immunology
Bioinformatics
Vaccine Development

Background:

Accurate prediction of Major Histocompatibility Complex (MHC) binding peptides is vital for T cell epitope discovery, impacting vaccine and immunotherapy development.
While MHC class I prediction tools are mature, MHC class II (MHC-II) predictors lag, hindering CD4+ T cell-mediated immune response modulation for therapies.
Generating large datasets of peptide-MHC-II interaction data is essential for improving bioinformatics predictors and advancing immunotherapy.

Purpose of the Study:

To address the limitations in MHC-II prediction tools by generating a substantial dataset of peptide-MHC-II binding interactions.
To validate a high-throughput method for acquiring interpretable binding data suitable for training predictive models.
To demonstrate a cost-effective and rapid strategy for generating large-scale MHC-II binding data.

Main Methods:

Utilized recombinant HLA-DRB1*01:01 and HLA-DRB1*03:01 molecules to analyze high-density peptide arrays.
Interrogated arrays containing 70,000 random peptides in triplicates to capture comprehensive binding specificities.
Employed a cost-effective approach with rHLA technology for rapid data generation.

Main Results:

Acquired binding data with systematic and interpretable information reflecting HLA-DR molecule specificity.
Demonstrated the suitability of the generated data for training predictors to identify T cell epitopes and eluted peptides.
Achieved a low cost per peptide, enabling unprecedented speed in data generation.

Conclusions:

The developed strategy effectively generates large volumes of high-quality peptide-MHC-II binding data.
This approach significantly enhances the potential for improving MHC-II prediction tools and advancing immunotherapy development.
The method offers a scalable and efficient solution for epitope discovery and the creation of next-generation vaccines and therapies.